C[N+]1(C)CC2([N+](=O)[O-])CC=C(Oc3ccccc3)C([N+](=O)[O-])(C2)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?